Cardillo, Carmine
 Distribuzione geografica
Continente #
NA - Nord America 1.738
EU - Europa 1.737
AS - Asia 751
SA - Sud America 150
OC - Oceania 6
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.390
Nazione #
US - Stati Uniti d'America 1.719
DE - Germania 358
PL - Polonia 310
CN - Cina 281
SG - Singapore 248
SE - Svezia 235
IT - Italia 221
UA - Ucraina 182
BR - Brasile 142
IE - Irlanda 99
FR - Francia 77
RU - Federazione Russa 74
FI - Finlandia 57
ID - Indonesia 57
IN - India 56
GB - Regno Unito 48
BE - Belgio 27
TR - Turchia 26
KR - Corea 19
NL - Olanda 14
HK - Hong Kong 13
IR - Iran 13
MX - Messico 9
VN - Vietnam 9
AT - Austria 7
CA - Canada 7
CZ - Repubblica Ceca 7
CH - Svizzera 6
AU - Australia 5
ES - Italia 5
JP - Giappone 5
IQ - Iraq 4
DK - Danimarca 3
JO - Giordania 3
PK - Pakistan 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
CL - Cile 2
CO - Colombia 2
GT - Guatemala 2
MY - Malesia 2
OM - Oman 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CI - Costa d'Avorio 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
LY - Libia 1
MA - Marocco 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
SA - Arabia Saudita 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 4.390
Città #
Warsaw 306
Chandler 291
Ashburn 160
Singapore 158
Dublin 92
Fairfield 79
San Mateo 79
Jacksonville 77
Ann Arbor 74
Wilmington 71
Houston 67
Woodbridge 65
Jakarta 56
New York 55
Seattle 47
Milan 44
Nanjing 44
Cattolica 41
Boston 37
Beijing 35
Lawrence 33
Rome 32
Marseille 30
Moscow 30
Saint Petersburg 30
Dearborn 28
Nanchang 28
Munich 25
Cambridge 24
Brussels 20
Hefei 20
Redwood City 20
Los Angeles 19
Princeton 18
Helsinki 17
Bremen 16
Mountain View 15
Seoul 15
São Paulo 14
Hong Kong 13
Izmir 12
The Dalles 12
Boardman 9
Lancaster 9
Norwalk 9
University Park 9
Changsha 8
Hangzhou 8
Hebei 8
Jiaxing 8
London 8
Nürnberg 8
Shenyang 8
Tianjin 8
Bursa 7
Busto Arsizio 7
Pune 7
Brasília 6
Fremont 6
Corbetta 5
Kunming 5
Nuremberg 5
San Diego 5
Toronto 5
Washington 5
Campinas 4
Düsseldorf 4
Frankfurt am Main 4
Guangzhou 4
Leawood 4
Rio de Janeiro 4
Shanghai 4
Vienna 4
Zurich 4
Amman 3
Ankara 3
Brno 3
Brooklyn 3
Chicago 3
Detroit 3
Dong Ket 3
Falkenstein 3
Gent 3
Hyderabad 3
Jinan 3
Kish 3
Millbury 3
Naples 3
Natal 3
Prague 3
Redmond 3
Salvador 3
Simi Valley 3
Turku 3
Zhengzhou 3
Acton 2
Albuquerque 2
Augusta 2
Brisbane 2
Chelyabinsk 2
Totale 2.621
Nome #
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 324
Human obesity and endothelium-dependent responsiveness 277
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 152
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 148
Effects of GLP-1 on Forearm Vasodilator Function and Glucose Disposal During Hyperinsulinemia in the Metabolic Syndrome 135
Vascular Effects of Obestatin in Lean and Obese Subjects 117
Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review 115
Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy 107
Coexistence of functional angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans 99
Ghrelin Restores the Endothelin 1/Nitric Oxide Balance in Patients With Obesity-Related Metabolic Syndrome 93
Beneficial Effects of Apelin on Vascular Function in Patients with Central Obesity 93
Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity 91
Endothelial and perivascular adipose tissue abnormalities in obesity-related vascular dysfunction: novel targets for treatment 88
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 86
Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome 86
Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome 83
Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity 81
Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome. 80
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 80
Obesity and kidney disease: Beyond the hyperfiltration 80
CD26: a multi-purpose pharmacological target 78
Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome. 78
Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome 74
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease 73
Rho Kinase Inhibition Improves Forearm Vasodilator Responsiveness During Hyperinsulinemia in the Metabolic Syndrome. 70
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome 64
PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia 62
Gut hormones and endothelial dysfunction in patients with obesity and diabetes 61
Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue 61
Insulinemia and the risk of breast cancer and its relapse 59
Oxidative stress in diabetes: implications for vascular and other complications 57
Increased fractalkine and vascular dysfunction in obesity and in type 2 diabetes. Effects of oral antidiabetic treatment 57
Calcification biomarkers and vascular dysfunction in obesity and type 2 diabetes: influence of oral hypoglycemic agents. 57
Obesity, blood vessels and metabolic syndrome 56
Vascular hyperpolarization in human physiology and cardiovascular risk conditions and disease 55
Vascular hyperpolarization in human physiology and cardiovascular risk conditions and disease 53
Vasodilator Dysfunction in Human Obesity: Established and Emerging Mechanisms 53
Variable dysregulation of circulating lipocalin-2 in different obese phenotypes: Association with vasodilator dysfunction 51
Increased endothelin-1-mediated vasoconstrictor tone in human obesity: effects of gut hormones 51
Arterial ageing: from endothelial dysfunction to vascular calcification 51
Variable changes of circulating angptl3 and angptl4 in different obese phenotypes: Relationship with vasodilator dysfunction 51
Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque 49
Lp-PLA 2 , a new biomarker of vascular disorders in metabolic diseases 49
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 48
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 45
Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy 45
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome 45
Drug treatments to restore vascular function and diabesity 45
The vascular endothelin system in obesity and type 2 diabetes: Pathophysiology and therapeutic implications 44
Sex-specific effects of cardiovascular risk factors on endothelium-dependent dilation and endothelin activity in middle-aged women and men. 44
Exercise is medicine: key to cardiovascular disease and diabetes prevention 42
Intricacies of the endothelin system in human obesity: Role in the development of complications and potential as a therapeutic target 41
Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque 40
Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome. 37
Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity 31
Mirabegron relaxes arteries from human visceral adipose tissue through antagonism of α1-adrenergic receptors 29
Free-amino acid metabolic profiling of visceral adipose tissue from obese subjects 24
Anti-inflammatory and proliferative properties of luteolin-7-O-glucoside 22
Mirabegron relaxes arteries from human visceral adipose tissue through antagonism of α1-adrenergic receptors 22
Post-surgical spontaneous paroxysmal hypothermia: a case series 19
Is endothelin targeting finally ready for prime time? 14
Gut dysbiosis and western diet in the pathogenesis of essential arterial hypertension: A narrative review 13
The Role of Perivascular Adipose Tissue in the Pathogenesis of Endothelial Dysfunction in Cardiovascular Diseases and Type 2 Diabetes Mellitus 11
Role of L-type Ca2+-channels in the vasorelaxing response to finerenone in arteries of human visceral adipose tissue 9
Emerging pharmacological approaches for the treatment of arterial hypertension 6
Obesity-related changes in the vascular actions of insulin 4
Totale 4.465
Categoria #
all - tutte 21.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.261


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202048 0 0 0 0 0 0 0 0 0 0 0 48
2020/2021464 33 51 11 47 68 59 44 16 64 18 43 10
2021/2022388 33 32 8 17 32 13 5 69 20 29 63 67
2022/2023859 106 110 72 116 50 116 38 72 114 27 27 11
2023/2024485 21 133 14 17 23 82 40 30 7 19 31 68
2024/2025810 21 19 76 36 64 33 29 56 134 103 225 14
Totale 4.465